| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |